rhodioloside has been researched along with oleanolic acid in 4 studies
Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (oleanolic acid) | Trials (oleanolic acid) | Recent Studies (post-2010) (oleanolic acid) |
---|---|---|---|---|---|
621 | 2 | 519 | 4,169 | 31 | 2,404 |
Protein | Taxonomy | rhodioloside (IC50) | oleanolic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.045 | |
Phospholipase A2 | Homo sapiens (human) | 3 | |
DNA polymerase beta | Homo sapiens (human) | 6.8667 | |
DNA polymerase beta | Rattus norvegicus (Norway rat) | 5.6 | |
Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 1 | |
Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.065 | |
Tissue factor | Homo sapiens (human) | 0.005 | |
Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.38 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.8444 | |
Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.065 | |
M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.98 | |
Dual specificity protein phosphatase 3 | Homo sapiens (human) | 5.4 | |
Transcription factor p65 | Homo sapiens (human) | 2.4 | |
Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.065 | |
Protease | Human immunodeficiency virus 1 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
Chen, HL; Fan, Y; Xu, SH; Xu, W; Zhang, J | 1 |
Nie, Y; Yao, W | 1 |
Cao, X; Deng, Y; Li, H; Ren, X; Wang, M | 1 |
4 other study(ies) available for rhodioloside and oleanolic acid
Article | Year |
---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Application of tandem biotransformation for biosynthesis of new pentacyclic triterpenoid derivatives with neuroprotective effect.
Topics: Animals; Bacillus subtilis; Cobalt; Glycosylation; Glycyrrhetinic Acid; Molecular Conformation; Neurons; Neuroprotective Agents; Oleanolic Acid; PC12 Cells; Rats; Rhizopus; Streptomyces; Triterpenes | 2020 |
A Comprehensive Quality Evaluation Method Based on C
Topics: Antioxidants; Apigenin; Chromatography, High Pressure Liquid; Coumarins; Drugs, Chinese Herbal; Fruit; Glucosides; Glycosides; Isomerism; Ligustrum; Limit of Detection; Oleanolic Acid; Phenols; Pyrans; Reproducibility of Results; Triterpenes; Ursolic Acid | 2018 |
Analysis of five active ingredients of Er-Zhi-Wan, a traditional Chinese medicine water-honeyed pill, using the biopharmaceutics classification system.
Topics: Animals; Biological Availability; Caco-2 Cells; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Glucosides; Humans; Intestinal Absorption; Limit of Detection; Linear Models; Luteolin; Male; Oleanolic Acid; Permeability; Phenols; Pyrans; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Software; Solubility | 2020 |